Origins
A group of passionate dental doctors, dedicated in providing better oral treatment on periodontic and implant care.
2020
Foundation
With the help of Dr. Jiang, and Chairman Dr. Polo, KeKe MedTech is established by providing “from oral to health, in becoming the Global Pioneer in Oral Care
2021
2022
Launch
1.Clinic operation launched, revenue USD1 million.
2.Cooperaation signed with Taiwan medical centers and universities.
3.Initiated new drug indiction researchR&D
1.Finding Drug Repurposing in periodontic and implant care
2.Revenue USD1.2 million, set up research department2023
2024
Patents & Growth
1.End of 2024, acquired first Medical Material Class I product in healing gum after implant surgery.
2.Revenue USD2 Million
3.Started IPO plan with KPMGClinical Start
1.With Dr. Lin’s join, launching OPM-101 for Post Oral cancer care drug development, and NFAb-101 for periodontal segment
2.Kicking-off xHP-102 Microneedle patch for dental surgery care
3.Promoting Gum-derived Stemcell banking and reproduction business
4.Increasing capital to USD2.1 million2025
2026
Clinical Success
1.Plan to accomplish xHP-102 IND investigation
2.Study xHP-102 in VET market promotion
3.Prepare for the IPO filing